MUC1 is a useful molecular marker for malignant intraductal papillary mucinous neoplasms in pancreatic juice obtained from endoscopic retrograde pancreatography

Pancreas

Volumn 39, Issue 6, 2010, Pages 879-883

  Shimamoto, Tetsuya ^a   Tani, Masaji ^a   Kawai, Manabu ^a   Hirono, Seiko ^a   Ina, Shinomi ^a   Miyazawa, Motoki ^a   Shimizu, Atsushi ^a   Uchiyama, Kazuhisa ^a   Yokoyama, Shozo ^a   Tsutsumi, Masahiro ^b   Yamaue, Hiroki ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b Saiseikai Chuwa Hospital   (Japan)

Author keywords

CEA; hTERT; intraductal papillary mucinous neoplasm; MUC1; quantitative RT PCR

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; MOLECULAR MARKER; MUCIN 1; TELOMERASE REVERSE TRANSCRIPTASE;

AGED; ARTICLE; CARCINOMA IN SITU; CHRONIC PANCREATITIS; CLINICAL ARTICLE; CYTOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DNA SYNTHESIS; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MALE; PANCREAS CANCER; PANCREAS JUICE; PANCREAS RESECTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY;

ADENOCARCINOMA, MUCINOUS; AGED; CARCINOMA, PANCREATIC DUCTAL; CARCINOMA, PAPILLARY; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; FEMALE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HUMANS; MALE; MIDDLE AGED; MUCIN-1; PANCREATIC JUICE; PANCREATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 77955229463     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e3181d6ba04     Document Type: Article

References (14)

1. Hruban RH, Adsay NV, Compton A-SJ, et al. Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol. 2001;25: 579Y586.
2. Fritz S, Fernandez-del Castillo C, Mino-Kenudson M, et al. Global genomic analysis of intraductal papillary mucinous neoplasms of the pancreas reveals significant molecular differences compared to ductal adenocarcinoma. Ann Surg. 2009;249:440Y447.
3. Hirono S, Tani M, Kawai M, et al. Treatment strategy for intraductal papillary mucinous neoplasm of the pancreas based on malignant predictive factors. Arch Surg. 2009;144:345Y349.
4. Wada K, Kozarek R, Traverso L. Outcomes following resection of invasive and noninvasive intraductal papillary mucinous neoplasms of the pancreas. Am J Surg. 2005;189:632Y636.
5. Sohn TA, Yeo CJ, Cameron JL, et al. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg. 2004;239:788Y797.
6. Wang SE, Shyr YM, Chen TH, et al. Comparison of resected and non-resected intraductal papillary mucinous neoplasms of the pancreas. World J Surg. 2005;29:1650Y1657.
7. Kawai M, Uchiyama K, Tani M, et al. Clinicopathological features of malignant intraductal papillary mucinous tumors of the pancreas: the differential diagnosis from benign entities. Arch Surg. 2004;139: 188Y192.
8. Ohuchida K, Mizumoto K, Yamada D, et al. Quantitative analysis of human telomerase reverse transcriptase in pancreatic cancer. Clin Cancer Res. 2006;12:2066Y2069.
9. Sandra J. MUC1 in renaissance molecule. J Mammary Gland Biol Neoplasia. 2001;6:339Y353.
10. Kigure S. Immunohistochemical study of the association between the progression of pancreatic ductal lesions and the expression of MUC1, MUC2, MUC5AC, and E-cadherin. Rinsho Byori. 2006;54:447Y452.
11. Ito H, Endo T, Oka T, et al. Mucin expression profile is related to biological and clinical characteristics of intraductal papillaryYmucinous tumors of the pancreas. Pancreas. 2005;30:e96Ye102.
12. Uehara H, Nakaizumi A, Iishi H, et al. In situ telomerase activity in pancreatic juice may discriminate pancreatic cancer from other pancreatic diseases. Pancreas. 2008;36:236Y240.
13. Feng J, Funk WD, Wang S, et al. The RNA component of human telomerase. Science. 1995;269:1236Y1241.
14. Hashimoto Y, Murakami Y, Uemura K, et al. Detection of human telomerase reverse transcriptase (hTERT) expression in tissue and pancreatic juice from pancreatic cancer. Surgery. 2008;143:113Y125.